Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated trastuzumab in combination with capecitabine and oxaliplatin as first-line chemotherapy for inoperable, locally advanced or metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Peking University | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED